[Adverse effects of calcium antagonists and beta-blockers].
Hasegawa
Junichi
J
Division of Pharmacotherapeutics, Department of Pathophysiological Science, Faculty of Medicine, Tottori University.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D032083:Citrus paradisi; D003329:Coronary Vasospasm / Q000139:chemically induced; D003863:Depression / Q000139:chemically induced; D003864:Depression, Chemical; D004347:Drug Interactions; D018565:Food-Drug Interactions; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D052439:Lipid Metabolism Disorders / Q000139:chemically induced; D009200:Myocardial Contraction / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers